Two biotechnology executives in Research Triangle Park are joining the advisory board for the BioPharma Management Initiative at N.C. State.

Rod Lindberg, who is director of the business acceleration and technology out-licensing network at the North Carolina Biotechnology Center, and Janice Whitaker, senior vice president at GlaxoSmithKline, will boost the advisory board’s membership to 15.

The biopharma program is part of NCSU’s College of Management. Launched in 2007, it is designed to help boost education and resources for the biotech industry.